BCL3 and triple-negative breast carcinoma: Suppression of BCL3 led to the upregulation of TNF-alpha and IL-6 and the downregulation of IL-10 in MDA-MB-231 triple-negative breast cancer cells [111], all of which would theoretically stimulate the recruitment and activation of immune cells within the tumour microenvironment [129].